drugset / Trial / NCT00242554
Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the effects of i.v. zoledronic acid 4 mg with respect to safety and tolerability
Timeline
- Start
- 2002-10
- Primary completion
- 2007-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | 4 mg | Intravenous |